Integer (NYSE:ITGR) EVP Diron Smith Acquires 1,116 Shares

Integer Holdings Corporation (NYSE:ITGR) EVP Diron Smith acquired 1,116 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The shares were acquired at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the acquisition, the executive vice president directly owned 7,698 shares of the company’s stock, valued at $517,228.62. This trade represents a 16.96% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Integer Stock Performance

NYSE ITGR opened at $69.29 on Monday. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $146.36. The business’s 50-day moving average price is $95.47 and its 200 day moving average price is $108.90. The company has a market capitalization of $2.43 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 0.60 and a beta of 0.95.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same period last year, the company earned $1.43 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, November 4th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

Institutional Trading of Integer

Institutional investors have recently bought and sold shares of the business. Salomon & Ludwin LLC purchased a new position in shares of Integer in the third quarter worth about $26,000. SVB Wealth LLC acquired a new position in Integer during the first quarter worth $35,000. Global Retirement Partners LLC increased its holdings in Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 238 shares in the last quarter. CWM LLC increased its holdings in Integer by 46.1% during the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 112 shares in the last quarter. Finally, MAI Capital Management grew its holdings in shares of Integer by 220.9% during the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 254 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on ITGR shares. Piper Sandler lowered their target price on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Citigroup lowered their price objective on shares of Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a research report on Monday, November 3rd. Bank of America downgraded shares of Integer from a “buy” rating to a “neutral” rating and set a $87.00 target price on the stock. in a research report on Friday, October 24th. Raymond James Financial restated an “outperform” rating and issued a $95.00 price objective (down previously from $143.00) on shares of Integer in a research note on Friday, October 24th. Finally, KeyCorp decreased their price objective on shares of Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Four analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $96.75.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.